Cargando…

Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening

Background: Small cell lung cancer (SCLC) is characterized by extreme invasiveness and lethality. There have been very few developments in its diagnosis and treatment over the past decades. It is urgently needed to explore potential novel biomarkers and drug targets for SCLC. Methods: Two-sample Men...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yijun, Wang, Zhile, Yang, Yuqi, Han, Chang, Wang, Li, Kang, Kai, Zhao, Ailin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511877/ https://www.ncbi.nlm.nih.gov/pubmed/37745050 http://dx.doi.org/10.3389/fphar.2023.1266782

Ejemplares similares

Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses
por: Wu, Yijun, et al.
Publicado: (2023)

Future implications of ChatGPT in pharmaceutical industry: drug discovery and development
por: Zhao, Ailin, et al.
Publicado: (2023)

Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer
por: Alam, Md Shahin, et al.
Publicado: (2022)

Identification of Multi-Target Anti-AD Chemical Constituents From Traditional Chinese Medicine Formulae by Integrating Virtual Screening and In Vitro Validation
por: Zhang, Baoyue, et al.
Publicado: (2021)

4D label-free quantitative proteomics analysis to screen potential drug targets of Jiangu Granules treatment for postmenopausal osteoporotic rats
por: Lin, Haiming, et al.
Publicado: (2022)

Long-term radiation therapy-related risk of second primary malignancies in patients with lung cancer
por: Han, Chang, et al.
Publicado: (2021)

To explore the effect of kaempferol on non-small cell lung cancer based on network pharmacology and molecular docking
por: Zhang, Junli, et al.
Publicado: (2023)

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer
por: Wang, Zhile, et al.
Publicado: (2020)

Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
por: Pastor-Anglada, Marçal, et al.
Publicado: (2015)

Elevated N-Glycosylation Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Cells Revealed by Membrane Proteomic and Glycoproteomic Analysis
por: Zeng, Wenjuan, et al.
Publicado: (2021)

Exploration the Mechanism of Doxorubicin-Induced Heart Failure in Rats by Integration of Proteomics and Metabolomics Data
por: Yuan, Yu, et al.
Publicado: (2020)

Toxicokinetics of Arenobufagin and its Cardiotoxicity Mechanism Exploration Based on Lipidomics and Proteomics Approaches in Rats
por: Zhao, Lijuan, et al.
Publicado: (2021)

Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non‐small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Targeting glycolysis in non-small cell lung cancer: Promises and challenges
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Small molecules targeting Pin1 as potent anticancer drugs
por: Zhang, Jing, et al.
Publicado: (2023)

Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review
por: Sun, Ruizheng, et al.
Publicado: (2019)

MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer
por: Sun, Lei, et al.
Publicado: (2021)

A Quantitative Serum Proteomic Analysis Helps to Explore the Comprehensive Mechanism and Identify Serum Biomarkers of Shengmai Injection’s Effect on Isoproterenol-Induced Myocardial Ischemia in Rats
por: Zhang, Xiaoping, et al.
Publicado: (2021)

Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2022)

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
por: Wang, Cong, et al.
Publicado: (2018)

Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study
por: Dong, Qin, et al.
Publicado: (2015)

Identification of a Novel Protein Arginine Methyltransferase 5 Inhibitor in Non-small Cell Lung Cancer by Structure-Based Virtual Screening
por: Wang, Qianqian, et al.
Publicado: (2018)

A Repurposed Drug Screen for Compounds Regulating Aquaporin 5 Stability in Lung Epithelial Cells
por: Villandre, John, et al.
Publicado: (2022)

Identification of super-enhancer-driven peptidyl arginine deiminases as potential biomarkers and therapeutic targets for osimertinib-resistant non-small cell lung cancer
por: Li, Hang, et al.
Publicado: (2022)

Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)
por: Wu, Yijun, et al.
Publicado: (2020)

Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac
por: Dragoi, Diana, et al.
Publicado: (2018)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Novel Murine Biomarkers of Radiation Exposure Using An Aptamer-Based Proteomic Technology
por: Sproull, Mary, et al.
Publicado: (2021)

Thermal proteome profiling reveals Haemonchus orphan protein HCO_011565 as a target of the nematocidal small molecule UMW-868
por: Taki, Aya C., et al.
Publicado: (2022)

Peptides/Proteins Encoded by Non-coding RNA: A Novel Resource Bank for Drug Targets and Biomarkers
por: Zhu, Song, et al.
Publicado: (2018)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies
por: Vähätupa, Maria, et al.
Publicado: (2020)

Recent progress in targeted therapy for non-small cell lung cancer
por: Xiao, Yanxia, et al.
Publicado: (2023)

Identification of pharmacokinetic markers for safflower injection using a combination of system pharmacology, multicomponent pharmacokinetics, and quantitative proteomics study
por: Shi, Peiying, et al.
Publicado: (2022)

Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies
por: Liguori, Nicholas R., et al.
Publicado: (2021)

Effect of Wenxia Changfu Formula Combined With Cisplatin Reversing Non-Small Cell Lung Cancer Cell Adhesion-Mediated Drug Resistance
por: Wang, Meng-Ran, et al.
Publicado: (2020)

Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation
por: Ma, Chuanrui, et al.
Publicado: (2022)

Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19
por: Li, Liyuan, et al.
Publicado: (2022)

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
por: Huang, Lu, et al.
Publicado: (2022)

Case report: Indolent drug-related pneumonitis with alectinib therapy in the treatment of non-small cell lung cancer
por: Chen, Xianmeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r25svh6p794u6jphdcv07s5hmf